Logo

About the Institute

The Institute of Biotechnology and Molecular Medicine (IBMM) is an independent research institution that creates an elite center in biomedical research. IBMM's activity focuses on the implementation of integrative and innovative research. This goal is achieved by obtaining financing and developing international cooperation networks. The scope of the Institute's scientific activity includes biotechnology, medicine, diagnostics and molecular biology. However, the interdisciplinary character of many IBMM projects means that they are often participated by non-mainstream researchers in biomedical sciences. What's more, IBMM is actively involved in the transfer of technology and the development of projects with high commercial potential. Through a network of local and international partners, fast technology transfer is achieved to effectively create spin-off ventures.

The goal of IBMM is to support the advance of science and education through research, development, and innovation.

Management of the Institute:

Doctor Image

Dr. Eng. Dawid Nidzworski

Entrepreneur and scientist, Manager of Innovation (GFKM), happy husband and father of two children. A graduate of the Faculty of Chemistry of the Gdańsk University of Technology and the Intercollegiate Faculty of Biotechnology of UG-MUG.

Doctor Image

Dr. Paweł Schweiger

He has over ten years of experience in planning, running and commercializing the results of basic and applied research in the biomedical sector. Co-author of patents and scientific articles on an international scale.

Institute Council

Doctor Image

Associate Professor, Eng. Robert Bogdanowicz

chairman of the Council

Associate Professor, Eng. Robert Bogdanowicz works in the Department of Metrology and Optoelectronics, ETI PG Faculty (from 2000), building electronic nanodevices constructed of doped semiconductor thin-layer diamond.

Doctor Image

Professor Tadeusz Ossowski

Tadeusz Ossowski is a full professor at the Department of Analytical Chemistry of the University of Gdańsk.He has experience in the synthesis and separation of organic compounds.

Doctor Image

Dr. Alex Klarman

The leader of Goldratt Institute (Israel) and the president of his executive arm, Question Mark Ltd., leads the activities aimed at establishing the Limitation Theory (TOC) as a management standard all over the world, but especially in Israel and Poland. Dr. Alex Klarman is an international expert in the field of critical chain management.

Doctor Image

MD Ph.D. Robert Krzysztof Jarema

Doctor, entrepreneur, enthusiast. MD Ph.D. Robert Krzysztof Jarema has many years of experience in the field of urology, oncology, and general surgery.

Doctor Image

dr inż. Katarzyna Pala

Doctor of biotechnology at the Faculty of Biotechnology of the University of Wrocław.She completed the "Technology Broker" course at the School of Banking in Wroclaw, as well as postgraduate studies at the Jagiellonian University on two faculties: Industrial Pharmacy and Intellectual Property Law.

Doctor Image

Dr. Eng. Krzysztof Urbański

A graduate of the Faculty of Electronics at the Wrocław University of Technology, majoring in IT. Doctor of technical sciences in the field of electronics at the Faculty of Electronics of Microsystems and Photonics.

Doctor Image

Dr Eng. Łukasz Janus

Dr Eng. Łukasz Janus, biotechnologist, graduate of the University of Life Sciences and the Adam Mickiewicz University in Poznań. Doctoral thesis defended in 2012 in the discipline of biotechnology in the field of plant biotechnology.

Doctor Image

Tomasz Gondek

Tomasz Gondek has over 16 years of professional experience and cooperates with the Innovation Consulting Deloitte team, where it uses its expertise, among other things, collaborating with public research and development centers.

Our offer

The goal of IBMM is to support the development of science and education through research, development, and innovation. We invite you to cooperate with all who want to work in their team, on their projects. We offer laboratory, administrative and logistic facilities. We provide flexible forms of cooperation but, above all, a new quality in managing and developing innovative projects. If you have any idea for research, product or dissemination project, please contact us.

News

IBMM was again appreciated by The National Centre for Research and Development!

15 August 2019

IBMM was again appreciated by The National Centre for Research and Development! From the European Regional Development Fund, together with UroScan Ltd., we received a grant of over PLN 8 million to develop a fast and non-invasive BladderDx diagnostic test for the early diagnosis of bladder cancer. Comprehensive work will last until 2021 and will result in the implementation of a test that will support doctors not only in the diagnosis of bladder cancer but also in the study of treatment progress and recurrence of the disease. This is another IBMM’s grant, thanks to which we are increasingly expanding our research portfolio.

We are constantly inviting ambitious scientists to cooperate and to jointly implement projects. If you want to implement your own project, do not hesitate and contact us!

QUNNA „The innovative project QUNNA „Nanosensorics and imaging utilizing quantum effects – the synergy of glass and diamond for applications in the new generation of biodiagnostics”

21 March 2019
Capsule blog header image

The innovative project QUNNA „Nanosensorics and imaging utilizing quantum effects – the synergy of glass and diamond for applications in the new generation of biodiagnostics” has been awarded funding (4.3 mln EUR) in a prestigious TEAM-NET call organized by the Foundation for Polish Science (2nd rank on the list). The project will be carried out by a consortium of University of Warsaw, Jagiellonian University of Cracow, Gdańsk University of Technology PolitechnikaGda and Institute of Biotechnology and Molecular Medicine (IBMM).

The aim of the project is to apply phenomena of quantum physics for deployment of nanodiamond based technologies into innovative sensors that could be utilized in optical and magnetic research, electronics and medical diagnostics

Within the 4 year-long project, scientists will explore new materials, components and photonic systems displaying specific magnetic and optical properties. The resulting optoelectronic solutions will be introduced to the market in order to advance diagnostics of neurodegenerative diseases and cancer, among others.

The aim of the first edition of the TEAM-NET program organized by the Foundation for Polish Science is to enable far-reaching projects carried out by a network of cooperating research teams managed by outstanding scientists. Only 5 out of 39 submitted projects were approved by a panel of distinguished experts.

The ability to participate in such an ambitious project is a great honor for IBMM. Joining the community of the best scientific institutions in Poland will allow us to continue our dynamic growth based on the highest level of research and development activities.

techmatstrateg

IBMM is one of the beneficiaries of the TECHMATSTRATEG

19 November 2018

One of the winners of the NCBiR competition "Modern material technologies" - TECHMATSTRATEG is the Institute of Biotechnology and Molecular Medicine in Gdańsk (IBMM), which joined the scientific consortium with the leader: The Institute of Ceramics and Building Materials and the University of Gdańsk, Wrocław University of Technology and SensDx SA. The consortium received PLN 6.92 million for the implementation of the project entitled "Multifunctional composite material with antimicrobial and pro-regenerative properties for the reconstruction of bone tissue GlassPoPep". The project concerns the creation of a multifunctional composite material with antimicrobial and pro-regenerative properties for the reconstruction of the bone tissues. The production of such biomaterial will significantly accelerate the treatment process and eliminate many postoperative complications. For IBMM it is the first project from the TECHMATSTRATEG group and thanks to that we have become a member of an elite scientific group in the country. IBMM tasks will include work on new materials. We congratulate all the winners!

Another project from the National Center for Research and Development for the Institute of Biotechnology and Molecular Medicine in Gdańsk!

19 November 2018

IBMM in a consortium with SensDx S.A received funding for research and development on an innovative, fast and cheap test to detect Streptococcus pyogenes and pneumoniae with the identification of antibiotic resistance genes. The project concerns the development and implementation to the market of Point of Care devices for the rapid identification of Streptococcus pyogenes and Streptococcus pneumoniae with the identification of antibiotic resistance genes. The total co-financing amount is over PLN 7 million! Congratulations and we wish you continued success!

The EquineDx project has obtained financing:

19 November 2018

We are pleased to inform you that the Institute of Biotechnology and Molecular Medicine in Gdańsk in cooperation with SensDx S.A. received funding from the National Center for Research and Development for the implementation of the EquineDx project - a quick test for the detection of pathogens in horses. The subject of the project is the development and implementation of a rapid test for the diagnosis of infections with viruses and bacteria in horses, i.e. S. equi, herpesviruses EHV-1 and EHV-2 and viruses of arteritis. The total amount of funding is over PLN 6 million! Congratulations and we wish you continued success!

Biolumo

Applied Biosciences Scientific Journal

19 July 2018

We are very pleased to inform you that the Institute of Biotechnology and Molecular Medicine is the publisher of the scientific journal Applied Biosciences (ISSN 2545-2215). It is a journal publishing the latest scientific reports from the fields of basic and applied research in the English language. The magazine has their own DOI prefix and follows the COPE’s Ethical Guidelines. We invite you to publish!

Journal Website
Biolumo

Cooperation with BIOLUMO

May 4, 2018

The Institute of Biotechnology and Molecular Medicine together with BIOLUMO will work on an innovative method of testing antibiotic resistance in veterinary medicine. The consortium obtained funding from the National Center for Research and Development in the amount of nearly PLN 10 million for this purpose. We congratulate the design team.

wd-tech

Cooperation with WDTECH

May 4, 2018

We are delighted to inform you that the project implemented by the Institute of Biotechnology and Molecular Medicine in cooperation with WDtech obtained funding from the National Center for Research and Development for the development and implementation of an innovative solution for athletes. The value of the project is nearly 10 million PLN. We congratulate the design team.

Top100

Our publication in Top 100 Scientific Reports Chemistry papers in 2017

March 29, 2018

We are pleased to announce that the publication of our employees in cooperation with SensDx was among the top 100 in 2017 despite its release in November.

Look up Top 100 Articles
Capsule blog header image

Scientific Reports

November 16, 2017

We are pleased to inform you that the results of research carried out in an interdisciplinary team have been published in the prestigious journal Scientific Reports.

Show Article
Capsule blog header image

Bacillus Subtilis

June 30, 2017

Properties of spores Bacillus Subtilis - another publication with the participation of our employees.

Show Article
Capsule blog header image

Człowiek Nauka Środowisko

June 10, 2017

Institute of Biotechnology and Molecular Medicine a partner of the conference. „Człowiek Nauka Środowisko”

Show more
Capsule blog header image

About telemedicine and its future

May 30, 2017

Global telemedicine is growing at a dizzying pace - over a dozen percent annually. – over a dozen percent annually.

Show article
Capsule blog header image

Coordination chemistry of pyrazine derivatives...

23 maj 2016

Publication in which our employees took part

Show article

INSTITUTE OF BIOTECHNOLOGY AND MOLECULAR MEDICINE

(National Court Register: 0000539819, Taxpayer Identification Number: 9571076610, National Business Registry Number: 360589614)

Trzy Lipy 3, 80-172 Gdańsk

(+48)587395886

LinkedIn